Alnylam Pharmaceuticals (ALNY) Q4 2020 Earnings

5NovConfirmed
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-2.57
-2.23
-1.9
-1.56

Details

Expected EPS
-1.68
Actual EPS
-2.18
Surprise EPS
-0.5
Surprise Percent
+29.76%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -2.18 per share for Q4 2020.

0 Comments

Share your thoughts